CATEGORY

Chromatography Resins

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Chromatography Resins.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Chromatography Resins Market Monitoring Dashboard


Supply Demand

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Chromatography Resins Industry Benchmarks


Savings Achieved

(in %)

The average annual savings achieved in Chromatography Resins category is 5.40%

Payment Terms

(in days)

The industry average payment terms in Chromatography Resins category for the current quarter is 73.4 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length

SLAs/KPIs

Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk

Sanctions

AMEs

Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Chromatography Resins Suppliers


    2,299
    Total Suppliers
    74
    Diverse Suppliers
    73
    Normalized Supplier Rating
    Chromatography Resins Supplier

    Find the right-fit chromatography resins supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    Catalent Inc.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    1
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    33

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    30
    Social
    26
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    34
    Human rights
    32
    Community Environment
    15
    Corporate governance
    56
    Human resources
    26
    Security Scorecard
    79

    Threat indicators
    A
    91
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    F
    52
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    D
    62
    Application Security
    Detecting common website application vulnerbilities
    A
    100
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    A
    100
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    90
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    catalent.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    0
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    0
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    0
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    0
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    21
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    Chromatography Resins market frequently asked questions


    Pharmaceutical manufacturers use chromatography resins to separate biomolecules, such as protein, monoclonal antibodies, antibody fragments, and vaccines. Moreover, subsequent advances in drug discovery are favoring the demand for chromatographic resins, which make up for around a third of the pharma industry.

    Pharmaceutical manufacturers use chromatography resins to separate biomolecules, such as protein, monoclonal antibodies, antibody fragments, and vaccines. Moreover, subsequent advances in drug discovery are favoring the demand for chromatographic resins, which make up for around a third of the pharma industry.

    The global chromatography resins market is highly consolidated, with the leading five players capturing about 70% of the overall revenue. Among them, GE Healthcare/Cytiva leads the pack with 30-40% revenue share. Further, these prominent market players are involved in research and development (R&D) projects to manufacture innovative and better resin beads.

    The global chromatography resins market is highly consolidated, with the leading five players capturing about 70% of the overall revenue. Among them, GE Healthcare/Cytiva leads the pack with 30-40% revenue share. Further, these prominent market players are involved in research and development (R&D) projects to manufacture innovative and better resin beads.

    The demand for chromatography resins has been rising since the advent of the COVID-19 crisis in developing vaccines. Moreover, several pharma companies have been witnessing price hikes and increased lead time over the last few months. Suppliers are proactively involved in workforce addition, portfolio expansions, and capacity addition, ensuring a sufficient supply of the critical raw material required for treating COVID-19 and manufacturing other drugs.

    The demand for chromatography resins has been rising since the advent of the COVID-19 crisis in developing vaccines. Moreover, several pharma companies have been witnessing price hikes and increased lead time over the last few months. Suppliers are proactively involved in workforce addition, portfolio expansions, and capacity addition, ensuring a sufficient supply of the critical raw material required for treating COVID-19 and manufacturing other drugs.

    The need for more monoclonal antibodies (MAB) and precise methods are mainly fueling the demand for chromatographic resins. In addition, an upsurge in the number of contract manufacturing organizations (CMO) is adding another arm of growth.

    The need for more monoclonal antibodies (MAB) and precise methods are mainly fueling the demand for chromatographic resins. In addition, an upsurge in the number of contract manufacturing organizations (CMO) is adding another arm of growth.

    North America leads the demand for chromatography resins owing to the large-scale manufacturing of several biologic drugs. Moving ahead, the market growth in Europe is shooting, given the strong presence of biologic manufacturing facilities and at-length COVID-19 drug development.

    North America leads the demand for chromatography resins owing to the large-scale manufacturing of several biologic drugs. Moving ahead, the market growth in Europe is shooting, given the strong presence of biologic manufacturing facilities and at-length COVID-19 drug development.

    The Asian chromatography resins market, primarily represented by India and China, is growing stellar as the region is home to prominent biologic drug and vaccine manufacturers.

    The Asian chromatography resins market, primarily represented by India and China, is growing stellar as the region is home to prominent biologic drug and vaccine manufacturers.

    Chromatography Resins market report transcript


    Chromatography is a separation technique which involves a mobile phase (which drives the sample) and the stationary phase (which supports the purification). Chromatography resins constitute the stationary phase in the purification process.

    • Chromatography resin’s applications in pharma include separation of biomolecules like monoclonal antibodies, protein, antibody fragments and vaccines
    • Suppliers offer chromatography resins as standard or custom resins and also as prepacked columns. These resins can be used at varying scales from laboratory to pilot to large scale manufacturing

    Demand for chromatographic resins has been increasing with growth in drug discovery by major pharmaceutical companies. Pharmaceutical applications contribute to nearly 30 percent of the end-use market

    • Top five players in the market accounted for nearly 70 percent of the global chromatographic resins market in 2018. GE Healthcare/Cytiva is the market leader with 30-40 percent market share
    • Chromatographic resins are majorly driven by the need for more monoclonal antibodies in the market and highly specific purification techniques

    Demand Market Outlook 

    Demand for chromatography resins has been increasing since the evolution of biologic drugs. It is seen to increase even more after the onset of COVID-19 and the development of vaccines and treatments for COVID-19.

    • North America has been supporting the manufacture of several biologic drugs and hence the demand is high in the region
    • Europe is home to most of the biologic manufacturing facilities and hence the demand is expected to be high, especially due to COVID-19 drug development
    • India and China have been driving the demand for chromatography resins in Asia. Major biologic drug and vaccine manufacturers are located in these regions

    Impact of COVID-19 on Chromatography Resins 

    • Many pharma companies have been experiencing increase in price and lead time during the past few months
    • Suppliers are seen to be actively involved in expansions, addition of man power, addition of capacity, etc. to make sure they supply the critical raw material needed for COVID-19 and other drug manufacturing

    Market Overview

    Demand for chromatographic resins has been increasing with growth in drug discovery by major pharmaceutical companies. Pharmaceutical applications contribute to nearly 30 percent of the end-use market.

    • The chromatography resins market expected to witness more growth due to a rise in the number of contract manufacturing organizations
    • Asian markets like China and India are seeing continuous growth in pharmaceuticals. This is expected to have a positive effect on the chromatography resins market
    • All major resin manufacturers have been involved in research and developmental activities to produce new and improved resin beads